BioCentury
ARTICLE | Clinical News

NeXstar regulatory update

April 24, 1995 7:00 AM UTC

NeXstar Pharmaceuticals Inc. (NXTR) The Boulder, Colo., company received notice of allowance for two U.S. Patents covering NXTR's DaunoXome liposomal daunorubicin. The inventions involve methods of d...